Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gum Tech (GUMM) -- Ignore unavailable to you. Want to Upgrade?

To: Mike M who wrote (17)	1/22/1999 11:59:00 PM
From: out_of_the_loop	Read Replies (1) \| Respond to of 133

Mike - All of that sounds very encouraging. Thanks for the informative post. It is nice for a seasoned GUMM investor to speak out. I am sure that there are many drugs that can be adapted to this delivery system. GUMM has the only FDA-approved packaging system for this modality. I think that uniqueness is a great attraction for this company's business potential and also for an investment. "Sublingual", of course, just literally means "under the tongue". The key is that the drug can, as you mentioned, bypass the stomach, reduce the side effects and time & trouble associated with gastric or intestinal absorption. I noticed you have Pfizer, too. Maybe we can suggest to them that they investigate making Viagra gum (with GumTech) instead of the nasal spray that was publicized early last week <g>. By the way, is there anything about their facilities you can share with the thread? Regards, Howard